drugset / Trial / NCT02370745

Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle

NCT02370745

Completed 40 enrolled University of Nottingham
RandomizedCrossoverSingle-blindBasic science

Summary

This study has two protocols the aims of which are: 1. To identify age-related effects of AA on incretin secretion and whether and to what extent AA exhibit a true incretin effect (gut- mediated increases in plasma insulin) in younger individuals. (Protocol 1) 2. To define the extra-pancreatic ''novel'', insulin independent effects of glucagon like peptide-1 (GLP-1) on postprandial muscle protein and glucose metabolism and microvascular blood flow. (Protocol 2)

Timeline

Start
2014-11
Primary completion
2018-03
Completion
2018-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject GIP Peptide
Subject GLP-1 Peptide Intravenous
Subject Insulin Protein / enzyme biologic Intravenous
Subject Intravenous amino acids Unknown 15 g Intravenous

Indications